Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

Edward S. Kim, Vera Hirsh, Tony S.K. Mok et al. · The Lancet · 2008

Cited by 1,242 works. doi:10.1016/s0140-6736(08)61758-4

Authors

References